RSS
3 Nov 2019

Green Valley Announces NMPA Approval Of Oligomannate For Mild To Moderate Alzheimer’s Disease

Author: admintech | Filed under: Press Release

Oligomannate , A New Oral Treatment For Mild To Moderate Alzheimer’s Disease The Only Approved Novel AD Treatment Globally Since 2003 SHANGHAI, Nov. 2, 2019 /PRNewswire/ — Shanghai Green Valley Pharmaceuticals (Green Valley) today announced that China’s National Medical Products…

This entry was posted on Sunday, November 3rd, 2019 at 7:17 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»